Multiple Myeloma News and Research

RSS
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
Computerized method helps better protect pharma patents

Computerized method helps better protect pharma patents

Excess weight responsible for cancers globally finds report

Excess weight responsible for cancers globally finds report

Research offers hope for patients with serious bone marrow cancer

Research offers hope for patients with serious bone marrow cancer

Allen Institute for Immunology to partner with CU Anschutz to understand dynamics of human immune system

Allen Institute for Immunology to partner with CU Anschutz to understand dynamics of human immune system

Allen Institute for Immunology: A new division focused on human immune system

Allen Institute for Immunology: A new division focused on human immune system

New method to visualize small-molecule interactions inside cells

New method to visualize small-molecule interactions inside cells

New technology for profiling genetic makeup of myeloma tumor cells developed

New technology for profiling genetic makeup of myeloma tumor cells developed

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Clinical trial investigators found non-compliant with requirement to report results on EU register

Clinical trial investigators found non-compliant with requirement to report results on EU register

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

Study gives new insights into how cells leverage GPCRs to control inflammation

Study gives new insights into how cells leverage GPCRs to control inflammation

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer